Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

45 ta ish

Ish: Data from Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer

  1. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers

    Chun Hei Antonio Cheung, Huang-Hui Chen, Ching-Chuan Kuo +4

    Maqola20092 iqtibos
    ABI

  2. Survivin, cancer networks and pathway-directed drug discovery

    Dario C. Altieri

    Sharh maqola20072 iqtibos
    ABI

  3. p27Kip1 Stabilization and G1 Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through Down-regulation of Cyclin E/Cyclin-dependent Kinase 2 and Skp1-Cullin-F-box Protein/Skp2 Ubiquitin Ligase

    Pengfei Li, Chunrong Li, Xiuhua Zhao +3

    Maqola20042 iqtibos
    ABI

  4. Differential subcellular localization of functionally divergent survivin splice variants

    Csaba Mahotka, Joerg Liebmann, Michael Wenzel +4

    Maqola20022 iqtibos
    ABI

  5. The Survivin Isoform Survivin-3B is Cytoprotective and can Function as a Chromosomal Passenger Complex Protein

    Shirley K. Knauer, Carolin Bier, P. Schlag +14

    Maqola20072 iqtibos
    ABI

  6. Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest

    Xiang Ling, Ralph J. Bernacki, Michael G. Brattain +1

    Maqola20042 iqtibos
    ABI

  7. Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line

    Zuojun Yue, Ana Xavier Carvalho, Zhenjie Xu +10

    Maqola20082 iqtibos
    ABI

  8. Survivin Modulates Microtubule Dynamics and Nucleation throughout the Cell Cycle

    Jack Rosa, Pedro M. Canovas, Ashraful Islam +2

    Maqola20062 iqtibos
    ABI

  9. Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic, and Therapeutic Potential

    Roland H. Stauber, Wolf J. Mann, Shirley K. Knauer

    Sharh maqola20072 iqtibos
    ABI

  10. Alternative Splice Variants of Survivin as Potential Targets in Cancer

    Janardhan Sampath, Louis M. Pelus, Janardhan Sampath

    Sharh maqola20072 iqtibos
    ABI

  11. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas

    Keiji Suga, Tetsuhisa Yamamoto, Yoshitaka Yamada +3

    Maqola20052 iqtibos
    ABI

  12. Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells

    Chioniso Patience Masamha, Doris M. Benbrook

    Maqola20092 iqtibos
    ABI

  13. c-Jun-NH2-kinase-1 Inhibition Leads to Antitumor Activity in Ovarian Cancer

    Pablo E. Vivas‐Mejía, Juliana M. Benito, Ariel Fernández +16

    Maqola20092 iqtibos
    ABI

  14. Mechanism of XIAP-Mediated Inhibition of Caspase-9

    Eric N. Shiozaki, Jijie Chai, Daniel J. Rigotti +6

    Maqola20032 iqtibos
    ABI

  15. Structural basis of IAP recognition by Smac/DIABLO

    Geng Wu, Jijie Chai, Tomeka Suber +4

    Maqola20002 iqtibos
    ABI

  16. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.

    Csaba Mahotka, Michael Wenzel, Erik Springer +2

    Maqola19992 iqtibos
    ABI

  17. A role for survivin in chemoresistance of endothelial cells mediated by VEGF

    Jennifer M. Tran, Zubin Master, Joanne Yu +3

    Maqola20022 iqtibos
    ABI

  18. IAP family proteins---suppressors of apoptosis

    Quinn L. Deveraux, John C. Reed

    Sharh maqola19992 iqtibos
    ABI

  19. Therapeutic Targeting of ATP7B in Ovarian Carcinoma

    Lingegowda S. Mangala, Vesna Zuzel, Rosemarie Schmandt +18

    Maqola20092 iqtibos
    ABI

  20. Survivin expression in ovarian cancer.

    Z Liguang, L Peishu, M Hongluan +4

    Maqola20072 iqtibos
    ABI